Moreover, higher IL-33 expression is associated with poor overall survival (OS) and recurrence-free survival (RFS) in patients with gliomas (14, 15, 83), indicating that IL-33 might be an independent prognostic marker for glioma. Here, IL33 is linked to glioma.